- Troubles de l’Érection
- Published:
Epidémiologie de la dysfonction érectile (2ème partie). Facteurs de risque
Epidemiology of erectile dysfunction (part 2). Risk factors
Andrologie volume 12, pages 323–331 (2002)
Resume
Les enquêtes épidémiologiques réalisées dans la population générale de nombreux pays et l’étude de populations ciblées (dont un exemple est l’enquête réalisée en France par Leriche et Jaudinot chez 7469 patients diabétiques, hypertendus ou les deux) ont mis en évidence de nombreux facteurs de risque de dysfonction érectile: diabète, hypertension artérielle, tabagisme, dyslipidémie, maladies cardio-vasculaires, troubles psychologiques, certains médicaments, insuffisance rénale chronique, facteurs liés au statut socio-économique et au mode de vie, obésité, symptômes du bas appareil urinaire, mauvais état général et cyclisme.
Les facteurs de risque cardio-vasculaires sont prédictifs de dysfonction érectile et actuellement la dysfonction érectile est souvent considérée comme une entité de lamaladie vasculaire ouendothéliale.
De nouvelles études sont nécessaires pour préciser les mécanismes physiopathologiques de certains facteurs de risque et l’intérêt éventuel de mesures de prévention.
Abstract
Epidemiological studies in the general population or target populations in several countries in the world have revealed a large number of risk factors for erectile dysfunction: diabetes mellitus, hypertension, smoking, dyslipidaemia, cardiovascular diseases, psychological disorders, certain medications, chronic renal failure, socioeconomic factors and lifestyle, obesity, lower urinary tract symptoms, poor health and bicycling.
Cardiovascular risk factors are predictors of erectile dysfunction and erectile dysfunction is now considered to be a manifestation of vascular disease.
Further studies are necessary to establish the pathophysiological mechanisms of certain risk factors and the possible value of preventive measures.
References
ANSONG K.S., LEWIS C., JENKINS P., BELL J.: Epidemiology of erectile dysfunction: a community-based study in rural New York State. Ann. Epidemiol., 2000, 10: 293–296.
ARAUJO A.B., JOHANNES C.B., FELDMAN H.A., DERBY C.A., McKiNLAY J.B.: Relation between psychosocial risk factors and incident erectile dysfunction: prospective results from the Massachusetts Male Aging Study. Am. J. Epidemiol., 2000, 152: 533–541.
AYTAC I.A., ARAUJO A.B., JOHANNES C.B., KLEINMAN K.P., McKINLAY J.B.: Socioeconomic factors and incidence of erectile dysfunction: findings of the longitudinal Massachussetts Male Aging Study. Soc. Sci. Med., 2000, 51: 771–778.
BARKSDALE J.D., GARDNER S.F.: The impact of first-line antihypertensive drugs on erectile dysfunction. Pharmacotherapy, 1999, 19: 573–581.
BEHR-ROUSSEL D., CHAMIOT-CLERC P., BERNABE J. et al.: L’hypertension artérielle: facteur de risque de l’insuffisance érectile — 1ère démonstration expérimentale. Communication au 96e Congrès de l’Association Française d’Urologie, 20–23 novembre 2002, Paris.
BORTOLOTTI A., FEDELE D., CHATENOUD L., et al.: Cigarette smoking: a risk factor for erectile dysfunction in diabetics. Eur. Urol., 2001, 40: 392–396.
BRAUN M., WASSMER G., KLOTZ T., REIFENRATH B., MATHERS M., ENGELMAN U.: Epidemiology of erectile dysfunction: results of the ‘Cologne Male Survey’. Int. J. Impot. Res., 2000, 12: 305–311.
BURCHARDT M., BURCHARDT T., BAER L. et al.: Hypertension is associated with severe erectile dysfunction. J. Urol., 2000, 164: 1188–1191.
CARSON C.C., PATEL M.P.: The epidemiology, anatomy, physiology, and treatment of erectile dysfunction in chronic renal failure patients. Adv. Ren. Replace. Ther., 1999, 6: 296–309.
CERQUEIRA J., MORAES M., GLINA S.: Erectile dysfunction: prevalence and associated variables in patients with chronic renal failure. Int. J. Impot. Res., 2002, 14: 65–71.
CHEW K.K., EARLE C.M., STUCKEY B.G., JAMROZIK K., KEOGH E.J.: Erectile dysfunction in general medicine practice: prevalence and clinical correlates. Int. J. Impot. Res., 2000, 12: 41–45.
CHUNG W.S., SOHN J.H., PARK Y.Y.: Is obesity an underlying factor in erectile dysfunction? Eur. Urol., 1999, 36: 68–70.
DERBY C.A., BARBOUR M.M., HUME A.L., McKINLAY J.B.: Drug therapy and prevalence of erectile dysfunction in the Massachusetts Male Aging Study cohort. Pharmacotherapy, 2001, 21: 676–683.
DERBY C.A., MOHR B.A., GOLDSTEIN I., FELDMAN H.A. JOHANNES CB, McKINLAY JB: Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk. Urology, 2000, 56: 302–306.
FEDELE D., COSCELLI C., CUCINOTTA D. et al.: Incidence of erectile dysfunction in Italian men with diabetes. J. Urol., 2001, 166: 1368–1371.
FEDELE D., COSCELLI C., SANTEUSANIO F. et al.: Erectile dysfunction in diabetic subjects in Italy. Gruppo Italiano Studio Deficit Erettile nei Diabetici. Diabetes Care, 1998, 21: 1973–1977.
FELDMAN H.A., GOLDSTEIN L., HATZICHRISTOU D.G., KRANE R.J., McKINLAY J.B.: Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J. Urol., 1994, 151: 54–61.
FELDMAN H.A., JOHANNES C.B., DERBY C.A. et al.: Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study. Prev. Med., 2000, 30: 328–338.
FRANKEL S.J., DONOVAN J.L., PETERS T.I. et al.: Sexual dysfunction in men with lower urinary tract symptoms. J. Clin. Epidemiol., 1998, 51: 677–685.
FRANZEN D., METHA A., SELFERT N., BRAUN M., HOPP H.W.: Effects of beta-blockers on sexual performance in men with coronary heart disease. A prospective, randomized and double blinded study. Int. J. Impot. Res., 2001, 13: 348–351.
GREENSTEIN A., CHEN J., MILLER H., MATZKIN H., VILLA Y., BRAF Z.: Does severity of ischemic coronary disease correlate with erectile function? Int. J. Impot. Res., 1997, 9: 123–126.
GRIMM R.H. Jr, GRANDITS G.A., PRINEAS R., et al.: Longterm effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS). Hypertension, 1997, 29: 8–14.
GRUNBAUM A., KHALEEG-UR-REHMAN, CARRIER S.: Bicycling and erectile dysfunction: a review of the literature. J. Sex. Reprod. Med., 2002, 2: 75–79.
GUAY A.T., PEREZ J.B., HEAT G.J.: Cessation of smoking rapidly decreases erectile dysfunction. Endoc. Pract., 1998, 4, 23–26.
HAKIM L.S., GOLDSTEIN I.: Diabetic sexual dysfunction. Endocrinol. Metab. Clin. North Am., 1996, 25: 379–400.
JENSEN J., LENDORF A., STIMPEL H., FROST J., IBSEN H., ROSENKILDE P.: The prevalence and etiology of impotence in 101 male hypertensive outpatients. Am. J. Hypertens., 1999, 12: 271–275.
JOHANNES C., ARAUJO A.B., FELDMAN H.A., DERBY C.A., McKINLAY J.B.: Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts Male Aging Study. J. Urol., 2000, 163: 460–463.
KIM S.W., PAICK J., PARK D.W., CHAE I., OH B.: Potential predictors of asymptomatic ischemic heart disease in patients with vasculogenic erectile dysfunction. Urology, 2001, 58: 441–445.
KLEIN R., KLEIN B.E., LEE K.E., MOSS S.E., CRUICKS-HANKS K.J.: Prevalence of self-reproted erectile dysfunction in people with long-term IDDM. Diabetes Care, 1996, 19: 135–141.
LAUMANN E.O., PAIK A., ROSEN R.C.: Sexual dysfunction in the United States: prevalence and predictors. J.A.M.A., 1999, 281: 537–544.
LEE I.C., SURRIDGE D., MORALES A., HEATON J.P.: The prevalence and influence of significant psychiatric abnormalities in men undergoing comprehensive management of organic erectile dysfunction. Int. J. Impot. Res., 2000, 12: 47–51.
LERICHE A., JAUDINOT E.O., SOLESSE DE GENDRE A.: Enquête sur la prévalence des troubles de l’érection et leur prise en charge chez des patients à risque suivis en consultation de médecine générale. Communication au 94ème Congrès de l’Association française d’urologie, Paris, 15–19 Novembre 2000, Résumé 03.
LEWIS R.W.: Epidemiology of erectile dysfunction. Urol. Clin. North Am., 2001, 28: 209–216.
McVAY K.T., CARRIER S., WESSELLS H.: Smoking and erectile dysfunction: evidence based analysis. J. Urol., 2001, 166: 1624–1632.
MALAVAUD B., ROSTAING L., RISCHMANN P., SARRAMON J.P., DURAND D.: High prevalence of erectile dysfunction after renal transplantation. Transplantation, 2000, 69: 2121–2124.
MANNINO D.M., KLEVENS R.M., FLANDERS W.D.: Cigarette smoking: an independent risk factor for impotence? Am. J. Epidemiol., 1994, 140: 1003–1008.
MARCEAU L., KLEINMAN K., GOLDSTEIN I., McKINLAY J.: Does bicycling contribute to the risk of erectile dysfunction? Results from the Massachusetts Male Aging Study (MMAS). Int. J. Impot. Res., 2001, 13: 298–302.
MARTIN-MORALES A., SANCHEZ-CRUZ J.J., SAENZ DE TEJADA I., RODRIGUEZ-VELA L., JIMENEZ-CRUZ J.F., BURGOS-RODRIGUEZ R.: Prevalence and independent risk factors for erectile dysfunction in Spain: results of the Epidemiologia de la Disfunction Erectil Masculina Study. J. Urol., 2001, 166: 569–574.
MEINHARDT W., KROPMAN R.F., VERMEIJ P., NIJEHOLT A.A., ZWARTENDIJK J.: The influence of medication on erectile function. Int. J. Impot. Res., 1997, 9: 17–26.
NETO A.F., DE FREITAS RODRIGUES M.A., SARAIVA FITTIPALDI J.A., MOREIRA E.D. Jr: The epidemiology of erectile dysfunction and its correlates in men with chronic renal failure on hemodialysis in Londrina, southern Brazil. Int. J. Impot. Res., 2002, 14 Suppl 2: 19–26.
O’KANE P.D., JACKSON G.: Erectile dysfunction: is there silent obstructive coronary artery disease? Int. J. Clin. Pract., 2001, 55: 219–220.
PARAZZINI F., MENCHINI FABRIS F., BORTOLLI A.: Frequency and determinants of erectile dysfunction in Italy. Eur. Urol., 2000, 37: 43–49.
PINNOCK C.B., STAPLETON A.M., MARSHALL V.R.: Erectile dysfunction in the community: a prevalence study. Med. J. Aust., 1999, 171: 353–357.
ROSAS S.E., JOFFE M., FRANKLIN E. et al.: Prevalence and determinants of erectile dysfunction in hemodialysis patients. Kidney Int., 2001, 59: 2259–2266.
SAIRAM K., KULINSKAYA E., BOUSTEAD G.B., HANBURY D.C., McNICHOLAS T.A.: Prevalence of undiagnosed diabetes mellitus in male erectile dysfunction. Brit. J. Urol. Int., 2001, 88: 68–71.
SCHACHTER M.: Erectile dysfunction and lipid disorders. Curr. Med. Res. Opin., 2000, 16 Suppl 1: 9–12.
SIU S.C., LO S.K., WONG K.W., IP K.M., WONG Y.S.: Prevalence of and risk factors for erectile dysfunction in Hong Kong diabetic patients. Diabet. Med., 2001, 18: 732–738.
SULLIVAN M.E., MILLER M.A., BELL C.R. et al.: Fibrinogen, lipoprotein (a) and lipids in patients with erectile dysfunction. A preliminary study. Int. Angiol., 2001, 20: 195–199.
SULLIVAN M.E., THOMPSON C.S., DASHWOOD M.R. et al.: Nitric oxide and penile erection: is erectile dysfunction another manifestation of vascular disease? Cardiovasc. Res., 1999, 43: 658–665.
TENGS T.O., OSGOOD N.D.: The link between smoking and impotence: two decades of evidence. Prev. Med., 2001, 32: 447–526.
WEI M., MACERA C.A., DAVIS D.R., HORNUNG C.A., NANKIN H.R., BLAIR S.N.: Total cholesterol and high density lipoprotein cholesterol as important predictors of erectile dysfunction. Am. J. Epidemiol., 1994, 140: 930–937.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Delavierre, D. Epidémiologie de la dysfonction érectile (2ème partie). Facteurs de risque. Androl. 12, 323–331 (2002). https://doi.org/10.1007/BF03034649
Issue Date:
DOI: https://doi.org/10.1007/BF03034649